{"news_desk": "Business", "print_page": "", "section_name": "Business Day", "subsection_name": null, "document_type": "article", "multimedia": [], "abstract": null, "type_of_material": "News", "word_count": "327", "lead_paragraph": "The biotech company, the subject of a 2013 Supreme Court ruling that genes cannot be patented, said it was giving up trying to stop other companies from offering tests.", "pub_date": "2015-01-28T00:00:00Z", "_id": "54c8376538f0d8026925f12f", "byline": {"contributor": "", "original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "source": "The New York Times", "snippet": "The biotech company, the subject of a 2013 Supreme Court ruling that genes cannot be patented, said it was giving up trying to stop other companies from offering tests.", "web_url": "http://www.nytimes.com/2015/01/28/business/myriad-genetics-ending-patent-dispute-on-breast-cancer-risk-testing.html", "slideshow_credits": null, "blog": [], "keywords": [{"rank": "1", "is_major": "N", "value": "Inventions and Patents", "name": "subject"}, {"rank": "11", "is_major": "N", "value": "Myriad Genetics Inc", "name": "organizations"}, {"rank": "12", "is_major": "N", "value": "Pathway Genomics", "name": "organizations"}, {"rank": "13", "is_major": "N", "value": "Quest Diagnostics Inc", "name": "organizations"}, {"rank": "14", "is_major": "N", "value": "Laboratory Corporation of America Holdings", "name": "organizations"}, {"rank": "2", "is_major": "N", "value": "Genetics and Heredity", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Breast Cancer", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Tests (Medical)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Decisions and Verdicts", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Suits and Litigation (Civil)", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Cancer", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Biotechnology and Bioengineering", "name": "subject"}, {"rank": "9", "is_major": "N", "value": "Ambry Genetics", "name": "organizations"}, {"rank": "10", "is_major": "N", "value": "Counsyl Inc", "name": "organizations"}], "headline": {"main": "Myriad Genetics Ending Patent Dispute on Breast Cancer Risk Testing"}}